Blog

New Real-World Evidence Shows Average Cost Savings of $80,000 Per Child and Improved Health Outcomes Following Exome and Genome Testing

Landmark Study shows significant cost savings following exome and genome testing blog header with patient.

Landmark study shows significant cost savings following exome and genome sequencing in pediatric neurological conditions

Rare Disease Day: Moving Beyond Awareness for Rare Disease Patients and Providers

Together, we can go beyond aware for Rare Disease Day

Rare Disease Day is only the beginning. Learn why early diagnosis, quality genomic data, and advocacy must work together—and how GeneDx helps drive action for rare disease.

Why Year-End Is the Right Time to Order Genetic Testing

With annual deductibles potentially met, now is a particularly good time to pursue comprehensive genetic testing.

Genetic Testing Options For Children: A Comprehensive Guide

Child playing with bubbles

Finally—an easy-to-understand guide to pediatric genetic testing.

Unexplained epilepsy doesn’t have to remain unexplained. Even for adults, answers are within reach.

An occupational therapist works with a woman on her coordination and motor skills. They are doing a fun exercise putting pegs into a plastic board. The shot is over the patient's shoulder and is focused on the therapist.

Decades after an individual’s first unexplained seizure, a genetic diagnosis can still provide the clarity that they have been waiting for, and the chance for better outcomes.¹ It’s also more accessible than ever.

A useful tool for back-to-school concerns 

Girl doing homework

Seeing a spike in back-to-school concerns? AAP-recommended testing may help find answers sooner.

Celebrating NICU heroes, big and small 

Image of baby in NICU

This NICU Awareness Month, GeneDx celebrates the healthcare heroes navigating some of the most challenging beginnings—and is here to help.

Three hospitals. Two surgeries. One rare disease diagnosis. How a determined mom and dad fought for their newborn daughter to help her survive–and thrive.

Layla and family

An emergency transfer put their newborn in a hospital where a genetic study was in progress. It may have changed everything.  

From dismissed to diagnosed: A mom’s 4-year journey for answers—and what it meant for her son

Sarah knew something was wrong. The nosebleeds. The fatigue. The headaches. Her care team said she was fine. But her gut said otherwise. 

AAP recommends exome and genome sequencing for global developmental delay and intellectual disability